Detalles de la búsqueda
1.
The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer.
Eur J Nucl Med Mol Imaging;
49(10): 3470-3481, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35501518
2.
The radiomics-based tumor heterogeneity adds incremental value to the existing prognostic models for predicting outcome in localized clear cell renal cell carcinoma: a multicenter study.
Eur J Nucl Med Mol Imaging;
49(8): 2949-2959, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35344062
3.
Could Urinary Iodine Be an Effective Predictive Factor for Thyroid Cancer After High Dose Radioactive Iodine Therapy?
Endocr Pract;
28(6): 586-592, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35304327
4.
Comparative diagnostic accuracy of respective nuclear imaging for suspected fracture-related infection: a systematic review and Bayesian network meta-analysis.
Arch Orthop Trauma Surg;
141(7): 1115-1130, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32514833
5.
Potential Impact of Body Mass Index on the Clinical Outcome of Papillary Thyroid Cancer After High-Dose Radioactive Iodine Therapy.
Front Endocrinol (Lausanne);
13: 870530, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35721759
6.
Delay of initial radioactive iodine therapy beyond 3 months has no effect on clinical responses and overall survival in patients with thyroid carcinoma: A cohort study and a meta-analysis.
Cancer Med;
11(12): 2386-2396, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35179295
7.
Analysis of Curative Effect and Influencing Factors of N1 Stage Papillary Thyroid Micro-Carcinoma and Papillary Thyroid Non-Micro Carcinoma After Initial Radioactive Iodine Ablation Therapy.
Cancer Manag Res;
13: 1427-1434, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33613032
8.
Clinical Analysis of the Short-Term Outcome of Papillary Thyroid Micro Carcinoma After 131I Treatment.
Cancer Manag Res;
13: 4691-4698, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34163244
9.
Lymph node metastases >5 and metastatic lymph node ratio >0.30 of differentiated thyroid cancer predict response to radioactive iodine.
Cancer Med;
10(21): 7610-7619, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34622559
10.
Analysis of the incidence and influencing factors of hyponatremia before 131I treatment of differentiated thyroid carcinoma.
World J Clin Cases;
9(36): 11173-11182, 2021 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35071548
11.
A pre-ablative thyroid-stimulating hormone with 30-70 mIU/L achieves better response to initial radioiodine remnant ablation in differentiated thyroid carcinoma patients.
Sci Rep;
11(1): 1348, 2021 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33446744
12.
Preablative Stimulated Thyroglobulin and Thyroglobulin Reduction Index as Decision-Making Markers for Second Radioactive Iodine Therapy in Patients with Structural Incomplete Response.
Cancer Manag Res;
13: 5351-5360, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34262343
13.
Comparison of PET/CT and MRI in the Diagnosis of Bone Metastasis in Prostate Cancer Patients: A Network Analysis of Diagnostic Studies.
Front Oncol;
11: 736654, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34671558
14.
[Effects of endostatin on the growth and lymphangiogenesis of Lewis lung carcinoma xenograft in mice].
Zhonghua Yi Xue Za Zhi;
90(43): 3091-3, 2010 Nov 23.
Artículo
en Zh
| MEDLINE | ID: mdl-21211334
Resultados
1 -
14
de 14
1
Próxima >
>>